When grouped based on whether IgA, IgM, and IgG RF levels were below or above the cut-off value (denoted as negative or positive accordingly), there was no significant difference in any patient subsets (SS vs. SS-pa vs. SS+RA). This evidence concerns the gene CD79A and rheumatoid arthritis.